Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William S M Wold

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Methods in Molecular Medicine|April 3, 2007
Immunocompetent, semi-permissive cotton rat tumor model for the evaluation of oncolytic adenovirusesKaroly Toth, Jacqueline F Spencer, William S M Wold
Journal of Virology|August 27, 2010
Identification of a previously unrecognized promoter that drives expression of the UXP transcription unit in the human adenovirus type 5 genomeBaoling Ying, Ann E Tollefson, William S M Wold
Methods in Molecular Medicine|April 3, 2007
Use of the Syrian hamster as an animal model for oncolytic adenovirus vectorsMaria A Thomas, Jacqueline F Spencer, William S M Wold
Journal of Virology|June 28, 2003
Mutations within the ADP (E3-11.6K) protein alter processing and localization of ADP and the kinetics of cell lysis of adenovirus-infected cellsAnn E Tollefson, Abraham Scaria, Baoling Ying, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 16, 2009
Pre-existing immunity and passive immunity to adenovirus 5 prevents toxicity caused by an oncolytic adenovirus vector in the Syrian hamster modelDebanjan Dhar, Jacqueline F Spencer, Karoly Toth, et al.
Journal of Virology|December 17, 2008
Effect of preexisting immunity on oncolytic adenovirus vector INGN 007 antitumor efficacy in immunocompetent and immunosuppressed Syrian hamstersDebanjan Dhar, Jacqueline F Spencer, Karoly Toth, et al.
Methods in Molecular Medicine|April 3, 2007
A real-time PCR method to rapidly titer adenovirus stocksMaria A Thomas, Drew L Lichtenstein, Peter Krajcsi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 28, 2006
Targeting interferon-alpha increases antitumor efficacy and reduces hepatotoxicity of E1A-mutated spread-enhanced oncolytic adenovirusElena V Shashkova, Jacqueline F Spencer, William S M Wold, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 10, 2017
Targeting Interferon-α Increases Antitumor Efficacy and Reduces Hepatotoxicity of E1A-mutated Spread-enhanced Oncolytic AdenovirusElena V Shashkova, Jacqueline F Spencer, William S M Wold, et al.
Virology|October 3, 2002
Upregulation of the Golgi protein GP73 by adenovirus infection requires the E1A CtBP interaction domainRaleigh D Kladney, Ann E Tollefson, William S M Wold, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Methods in Molecular Medicine|April 3, 2007
Immunocompetent, semi-permissive cotton rat tumor model for the evaluation of oncolytic adenovirusesKaroly Toth, Jacqueline F Spencer, William S M Wold
Journal of Virology|August 27, 2010
Identification of a previously unrecognized promoter that drives expression of the UXP transcription unit in the human adenovirus type 5 genomeBaoling Ying, Ann E Tollefson, William S M Wold
Methods in Molecular Medicine|April 3, 2007
Use of the Syrian hamster as an animal model for oncolytic adenovirus vectorsMaria A Thomas, Jacqueline F Spencer, William S M Wold
Journal of Virology|June 28, 2003
Mutations within the ADP (E3-11.6K) protein alter processing and localization of ADP and the kinetics of cell lysis of adenovirus-infected cellsAnn E Tollefson, Abraham Scaria, Baoling Ying, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 16, 2009
Pre-existing immunity and passive immunity to adenovirus 5 prevents toxicity caused by an oncolytic adenovirus vector in the Syrian hamster modelDebanjan Dhar, Jacqueline F Spencer, Karoly Toth, et al.
Journal of Virology|December 17, 2008
Effect of preexisting immunity on oncolytic adenovirus vector INGN 007 antitumor efficacy in immunocompetent and immunosuppressed Syrian hamstersDebanjan Dhar, Jacqueline F Spencer, Karoly Toth, et al.
Methods in Molecular Medicine|April 3, 2007
A real-time PCR method to rapidly titer adenovirus stocksMaria A Thomas, Drew L Lichtenstein, Peter Krajcsi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 28, 2006
Targeting interferon-alpha increases antitumor efficacy and reduces hepatotoxicity of E1A-mutated spread-enhanced oncolytic adenovirusElena V Shashkova, Jacqueline F Spencer, William S M Wold, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 10, 2017
Targeting Interferon-α Increases Antitumor Efficacy and Reduces Hepatotoxicity of E1A-mutated Spread-enhanced Oncolytic AdenovirusElena V Shashkova, Jacqueline F Spencer, William S M Wold, et al.
Virology|October 3, 2002
Upregulation of the Golgi protein GP73 by adenovirus infection requires the E1A CtBP interaction domainRaleigh D Kladney, Ann E Tollefson, William S M Wold, et al.
Pageof 6